APO RESEARCH · REPORT
Cell Therapy
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Product & engineering
Understand the product.
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Selected research
Industry Research
Cell Therapy Industry Research Report 2026
Market perspective
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.
Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.
Read the full market overview
North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.
Report Scope
This report quantifies the global Cell Therapy market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Therapy Market by Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Cell Therapy Segment by Type
Stem Cell
Non-Stem Cell
Cell Therapy Segment by Application
Hospital
Clinic
Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell
- Non-Stem Cell
Applications
- Hospital
- Clinic
Companies covered
- Gilead Sciences
- Novartis
- Osiris
- Vericel Corporation
- Vcanbio
- Fujifilm Cellular Dynamics
- JCR Pharmaceuticals
- Beike Biotechnology
- Golden Meditech
- Guanhao Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cell
- 2.2.3 Non-Stem Cell
- 2.3 Cell Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Cell Therapy Breakdown Data by Type
- 3.1 Global Cell Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Therapy Forecasted Market Size by Type (2027-2032)
4 Cell Therapy Breakdown Data by Application
- 4.1 Global Cell Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Therapy Market Perspective (2021-2032)
- 5.2 Global Cell Therapy Growth Trends by Region
- 5.2.1 Global Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Therapy Market Dynamics
- 5.3.1 Cell Therapy Industry Trends
- 5.3.2 Cell Therapy Market Drivers
- 5.3.3 Cell Therapy Market Challenges
- 5.3.4 Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Therapy Players by Revenue
- 6.1.1 Global Top Cell Therapy Players by Revenue (2021-2026)
- 6.1.2 Global Cell Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Therapy Head Office and Area Served
- 6.4 Global Cell Therapy Players, Product Type & Application
- 6.5 Global Cell Therapy Manufacturers Established Date
- 6.6 Global Cell Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Therapy Market Size (2021-2032)
- 7.2 North America Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Therapy Market Size by Country (2021-2026)
- 7.4 North America Cell Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Therapy Market Size (2021-2032)
- 8.2 Europe Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Therapy Market Size by Country (2021-2026)
- 8.4 Europe Cell Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Therapy Market Size (2021-2032)
- 10.2 South America Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Therapy Market Size by Country (2021-2026)
- 10.4 South America Cell Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Gilead Sciences
- 12.1.1 Gilead Sciences Company Information
- 12.1.2 Gilead Sciences Business Overview
- 12.1.3 Gilead Sciences Revenue in Cell Therapy Business (2021-2026)
- 12.1.4 Gilead Sciences Cell Therapy Product Portfolio
- 12.1.5 Gilead Sciences Recent Developments
- 12.2 Novartis
- 12.2.1 Novartis Company Information
- 12.2.2 Novartis Business Overview
- 12.2.3 Novartis Revenue in Cell Therapy Business (2021-2026)
- 12.2.4 Novartis Cell Therapy Product Portfolio
- 12.2.5 Novartis Recent Developments
- 12.3 Osiris
- 12.3.1 Osiris Company Information
- 12.3.2 Osiris Business Overview
- 12.3.3 Osiris Revenue in Cell Therapy Business (2021-2026)
- 12.3.4 Osiris Cell Therapy Product Portfolio
- 12.3.5 Osiris Recent Developments
- 12.4 Vericel Corporation
- 12.4.1 Vericel Corporation Company Information
- 12.4.2 Vericel Corporation Business Overview
- 12.4.3 Vericel Corporation Revenue in Cell Therapy Business (2021-2026)
- 12.4.4 Vericel Corporation Cell Therapy Product Portfolio
- 12.4.5 Vericel Corporation Recent Developments
- 12.5 Vcanbio
- 12.5.1 Vcanbio Company Information
- 12.5.2 Vcanbio Business Overview
- 12.5.3 Vcanbio Revenue in Cell Therapy Business (2021-2026)
- 12.5.4 Vcanbio Cell Therapy Product Portfolio
- 12.5.5 Vcanbio Recent Developments
- 12.6 Fujifilm Cellular Dynamics
- 12.6.1 Fujifilm Cellular Dynamics Company Information
- 12.6.2 Fujifilm Cellular Dynamics Business Overview
- 12.6.3 Fujifilm Cellular Dynamics Revenue in Cell Therapy Business (2021-2026)
- 12.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
- 12.6.5 Fujifilm Cellular Dynamics Recent Developments
- 12.7 JCR Pharmaceuticals
- 12.7.1 JCR Pharmaceuticals Company Information
- 12.7.2 JCR Pharmaceuticals Business Overview
- 12.7.3 JCR Pharmaceuticals Revenue in Cell Therapy Business (2021-2026)
- 12.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
- 12.7.5 JCR Pharmaceuticals Recent Developments
- 12.8 Beike Biotechnology
- 12.8.1 Beike Biotechnology Company Information
- 12.8.2 Beike Biotechnology Business Overview
- 12.8.3 Beike Biotechnology Revenue in Cell Therapy Business (2021-2026)
- 12.8.4 Beike Biotechnology Cell Therapy Product Portfolio
- 12.8.5 Beike Biotechnology Recent Developments
- 12.9 Golden Meditech
- 12.9.1 Golden Meditech Company Information
- 12.9.2 Golden Meditech Business Overview
- 12.9.3 Golden Meditech Revenue in Cell Therapy Business (2021-2026)
- 12.9.4 Golden Meditech Cell Therapy Product Portfolio
- 12.9.5 Golden Meditech Recent Developments
- 12.10 Guanhao Biotech
- 12.10.1 Guanhao Biotech Company Information
- 12.10.2 Guanhao Biotech Business Overview
- 12.10.3 Guanhao Biotech Revenue in Cell Therapy Business (2021-2026)
- 12.10.4 Guanhao Biotech Cell Therapy Product Portfolio
- 12.10.5 Guanhao Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst